Patent US5807302A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5807302A Expired / Lapsed US ⏱️ 0.0 years remaining

Treatment of glaucoma

Assignee: Individual
•
Filing: 1996-04-01
•
Granted: 1998-09-15
•
Expires: 2016-04-01
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A treatment of glaucoma by direct flow of the aqueous humor through a slit passage in the cornea to the tear film, while maintaining sterility of the anterior chamber. A stent device, supported by the cornea, provides the passage, with a filter element therein to prevent bacterial incursion within the eye and to regulate aqueous humor flow. The filter may be replaceable, if necessary, by vacuum removal. The invention includes an installation device for cutting the slit and a device for gaping open the slit and for guiding and locking the stent into proper placement.

Inventors

  • 👤 Thaddeus Wandel

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 06:34
CPC Classifications
A; A61; A61F; A61F9/00; A61F9/007; A61F9/00781; A61F2/00; A61F2/82

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 113 words
A system for the insertion of a stent through the cornea of an eye, said system directly connecting an anterior chamber of the eye, having aqueous humor therein, to a tear film, for direct pressure relief from a glaucoma condition, said system comprising means for cutting a linear incision in the cornea, means for temporarily gaping open said linear incision, and a separate means for installing the stent within the linear incision while said incision is gaped open by the means for temporarily gaping open the linear incision, whereby when the stent is installed, the stent provides a passage for a direct connection between anterior chamber and the tear film through the cornea.
Claim 2
Independent Claim 113 words
A system for the insertion of a stent through the cornea of an eye, said system directly connecting an anterior chamber of the eye, having aqueous humor therein, to a tear film, for direct pressure relief from a glaucoma condition, said system comprising means for cutting a linear incision in the cornea, means for temporarily gaping open said linear incision, and a separate means for installing the stent within the linear incision while said incision is gaped open by the means for temporarily gaping open the linear incision, whereby when the stent is installed, the stent provides a passage for a direct connection between anterior chamber and the tear film through the cornea.
Claim 3
Dependent Claim 31 words
The system of claim 1, wherein the cutting means further comprises a collar whereby the incision is of a measured depth only sufficient to reach an interior surface of the cornea.
Claim 4
Dependent Claim 34 words
The system of claim 2, wherein the gaping means and installing means are integrated whereby gaping open of the incision with the gaping means aligns the stent for insertion within the gaped open incision.
Claim 5
Dependent Claim 37 words
The system of claim 3, wherein the gaping means comprise separated wing members extending in opposite directions, sized to fit within said incision adjacent walls of the incision, wherein rotation of the wing members effects the incision.
Claim 6
Dependent Claim 64 words
The system of claim 4, wherein a plunger is aligned in a space between the wing members, said plunger being adapted to engage an end of a stent placed in the space between the wing members whereby plunging activation of the plunger pushes the stent between the wing members into a position to connect the anterior chamber of the eye and the tear film.
Claim 7
Dependent Claim 131 words
A drainage stent for relief of excess pressure in an eye, resulting from a glaucoma condition, said stent being adapted to be placed through a cornea of the eye, in a transcorneal position, to directly connect an anterior chamber of the eye and a tear film on the outer surface of the cornea for direct fluid drainage from the anterior chamber and relief of excess pressure, said drainage stent comprising filtration means capable of preventing passage therethrough of bacteria, while permitting sufficient fluid drainage therethrough to relieve excess pressure, wherein the stent comprises a hollow tubular member having a pair of collar elements for respective engagement with an inner and outer surface of the cornea, and wherein the filter is positioned to block access of bacteria through the hollow tubular member.
Claim 8
Dependent Claim 131 words
A drainage stent for relief of excess pressure in an eye, resulting from a glaucoma condition, said stent being adapted to be placed through a cornea of the eye, in a transcorneal position, to directly connect an anterior chamber of the eye and a tear film on the outer surface of the cornea for direct fluid drainage from the anterior chamber and relief of excess pressure, said drainage stent comprising filtration means capable of preventing passage therethrough of bacteria, while permitting sufficient fluid drainage therethrough to relieve excess pressure, wherein the stent comprises a hollow tubular member having a pair of collar elements for respective engagement with an inner and outer surface of the cornea, and wherein the filter is positioned to block access of bacteria through the hollow tubular member.
Claim 9
Dependent Claim 22 words
The drainage stent of claim 6 wherein the filtration means comprises a microporous filter with a maximum pore size of 0.2 microns.
Claim 10
Dependent Claim 18 words
The drainage stent of claim 7, wherein the microporous filter is removable from the stent for replacement thereof.

References Cited (Backward Citations)

US4968296A Cited
US5092837A Cited
US5041081A Cited
US5127901A Cited
US5178604A Cited
US5300020A Cited
US5171213A Cited
US5326345A Cited
US5346464A Cited
US5370607A Cited
US5338291A Cited
US5433701A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-09-14 2002-03-16 2002-09-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-09-14 2006-03-16 2006-09-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-09-14 2010-03-16 2010-09-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag